Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03785873 |
| Title | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Michigan Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
| Cancer and Hematology Centers of Western Michigan | Grand Rapids | Michigan | 49503 | United States | Details | |
| University of Utah | Salt Lake City | Utah | 84132 | United States | Details | |
| Virginia Mason | Seattle | Washington | 98101 | United States | Details | |
| University of Wisconsin | Madison | Wisconsin | 53705 | United States | Details |